Catalyst Event
Samsung Biologics Co Ltd (207940) · Earnings Release
From Akros SCHK HK-Korea Cosmetics Index (ASHKCOS)
4/29/2026, 12:00:00 AM
Q1 2026 earnings release for April 29, 2026 scheduled. Minimal market impact from the date announcement expected.
Korean Translation
2026년 4월 29일 2026년 1분기 실적 발표 예정됨. 일정 발표에 따른 시장 영향은 제한적일 것으로 예상됨.
Related Recent Events
CSPC Pharmaceutical Group Ltd (1093) · Other
Final dividend of HKD 0.15 per share for FY2025 (total HKD 0.29, +11.5% YoY) with ex-dividend date June 24, 2026; low importance as dividend increases typically result in minor positive price adjustments scheduled.
6/24/2026, 12:00:00 AM
HLB Co Ltd (028300) · Other
An investor relations (IR) meeting to announce the group's integrated strategy and the progress of major pipelines; low impact anticipated as it is a routine communication event, scheduled.
4/9/2026, 12:00:00 AM
Celltrion Inc (068270) · Other
Cancellation of 9.11 million treasury shares, valued at approximately KRW 1.71 trillion, effective April 1, 2026. This largest-ever cancellation is expected to have a high market impact.
4/1/2026, 12:00:00 AM
Samchundang Pharm Co Ltd (000250) · Other
The 82nd Annual General Meeting of Shareholders on 2026-03-30 is a routine meeting with low expected price impact scheduled.
3/30/2026, 12:00:00 AM
Hanwha Corp (000880) · Other
The ex-dividend date for the 2025 final dividend of 1,100 KRW per common share is scheduled for 2026-03-30; market impact is estimated to be low (>=1%) following typical dividend adjustments, scheduled.
3/30/2026, 12:00:00 AM
Samsung Biologics Co Ltd (207940) · Other
The labor union, representing approximately 75% of the workforce, authorized a strike on March 29, 2026. Partial strikes are planned to begin on April 21, 2026, potentially escalating to a full-scale strike on May 1, 2026. High market impact due to potential production disruptions expected.
3/29/2026, 12:00:00 AM